Showing results (2411-2420 of 3,512) with videos related to

Sort By:
Pageof 352
Eclinicalmedicine|January 31, 2024
Efficacy and safety of pegzilarginase in arginase 1 deficiency (PEACE): a phase 3, randomized, double-blind, placebo-controlled, multi-centre trialRossana Sanchez Russo, Serena Gasperini, Gillian Bubb, et al.
Eclinicalmedicine|January 26, 2024
Estimating the return on investment of selected infection prevention and control interventions in healthcare settings for preparing against novel respiratory viruses: modelling the experience from SARS-CoV-2 among health workersEce Özçelik, Aliénor Lerouge, Michele Cecchini, et al.
Eclinicalmedicine|January 25, 2024
Prevalence of chronic cough, its risk factors and population attributable risk in the Burden of Obstructive Lung Disease (BOLD) study: a multinational cross-sectional studyHazim Abozid, Jaymini Patel, Peter Burney, et al.
Eclinicalmedicine|January 11, 2024
Donor-derived Anti-CD19 CAR T cells GC007g for relapsed or refractory B-cell acute lymphoblastic leukemia after allogeneic HSCT: a phase 1 trialYi Luo, Lei Gao, Jia Liu, et al.
Eclinicalmedicine|January 9, 2024
Beyond latent and active tuberculosis: a scoping review of conceptual frameworksSyed M A Zaidi, Anna K Coussens, James A Seddon, et al.
Eclinicalmedicine|March 28, 2024
The potential epidemiologic, clinical, and economic value of a universal coronavirus vaccine: a modelling studySarah M Bartsch, Kelly J O'Shea, Danielle C John, et al.
Eclinicalmedicine|March 28, 2024
Development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort studyDaniel T Myran, Lyndsay D Harrison, Michael Pugliese, et al.
Eclinicalmedicine|March 28, 2024
Effect of human milk-based fortification in extremely preterm infants fed exclusively with breast milk: a randomised controlled trialGeorg Bach Jensen, Magnus Domellöf, Fredrik Ahlsson, et al.
Eclinicalmedicine|March 28, 2024
Disproportionate infection, hospitalisation and death from COVID-19 in ethnic minority groups and Indigenous Peoples: an application of the Priority Public Health Conditions analytical frameworkPatricia Irizar, Daniel Pan, Harry Taylor, et al.
Eclinicalmedicine|March 28, 2024
Evaluation of all-cause mortality and cardiovascular safety in patients receiving chimeric antigen receptor T cell therapy: a prospective cohort studyFelix Korell, Lukas Entenmann, Sebastian Romann, et al.
Pageof 352